SCHEMBL92157

SCHEMBL92157

OCCOCCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1802846 0.97 MEN1 (0.73)
SCHEMBL2373680 0.97 MEN1 (0.73)
Di(Hydroxyethyl)Ether SCHEMBL2410410 0.84 TSHR (1.00)
Di(Hydroxyethyl)Ether SCHEMBL1462 0.84
SCHEMBL3306407 0.84
SCHEMBL331445 0.84
Di(Hydroxyethyl)Ether SCHEMBL28993299 0.81 TSHR (0.77)
Di(Hydroxyethyl)Ether SCHEMBL11310542 0.81 TSHR (0.77)
Di(Hydroxyethyl)Ether SCHEMBL4106731 0.81
SCHEMBL5145873 0.81 MEN1 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348384-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides UCB PHARMA GMBH (DE) 2023-11-02 US claimed
EP-3983384-B1 N-(PHENYL)-INDOLE-3-SULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS GPR17 MODULATORS FOR TREATING CNS DISORDERS SUCH AS MULTIPLE SCLEROSIS UCB PHARMA GMBH (DE) 2023-10-11 EP claimed
EP-3983384-A1 N-(PHENYL)-INDOLE-3-SULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS GPR17 MODULATORS FOR TREATING CNS DISORDERS SUCH AS MULTIPLE SCLEROSIS UCB Pharma GmbH (DE) 2022-04-20 EP claimed
CN-113993845-A N- (phenyl) -indole-3-sulfonamide derivatives and related compounds as GPR17 modulators for the treatment of CNS disorders, such as multiple sclerosis 优时比制药有限公司 2022-01-28 CN claimed
WO-2020254289-A1 N-(PHENYL)-INDOLE-3-SULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS GPR17 MODULATORS FOR TREATING CNS DISORDERS SUCH AS MULTIPLE SCLEROSIS UCB PHARMA GMBH (DE) 2020-12-24 WO claimed
US-11903702-B2 Multi-analyte sensing tissue-integrating sensors PROFUSA, INC. (US) 2024-02-20 US disclosed
WO-2024017856-A1 NOVEL ISOQUINOLINONE, PYRROLOPYRIDINONE AND THIENOPYRIDINONE SULFONAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2024-01-25 WO disclosed
US-20240025883-A1 PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2024-01-25 US disclosed
EP-4298092-A1 NOVEL PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2024-01-03 EP disclosed
US-11820746-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2023-11-21 US disclosed
US-20230348384-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides UCB PHARMA GMBH (DE) 2023-11-02 US disclosed
EP-3983384-B1 N-(PHENYL)-INDOLE-3-SULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS GPR17 MODULATORS FOR TREATING CNS DISORDERS SUCH AS MULTIPLE SCLEROSIS UCB PHARMA GMBH (DE) 2023-10-11 EP disclosed
US-20070031328-A1 Radiolabeled-pegylation of ligands for use as imaging agents NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2007-02-08 US disclosed
EP-1740579-A1 TRICYCLIC PYRAZOLE KINASE INHIBITORS Abbott Laboratories (US) 2007-01-10 EP disclosed
US-20060235075-A1 Analogous compounds of strobilurines and their use as acaricides and insecticides ISAGRO RICERCA S.R.L. (IT) 2006-10-19 US disclosed
US-20060014816-A1 Tricyclic pyrazole kinase inhibitors ABBVIE INC. 2006-01-19 US disclosed
WO-2005095387-A1 TRICYCLIC PYRAZOLE KINASE INHIBITORS ABBOTT LABORATORIES (US) 2005-10-13 WO disclosed
US-6852664-B2 Double metal cyanide catalysts for the preparation of polyether polyols BAYER AKTIENGESELLSCHAFT (DE) 2005-02-08 US disclosed
US-20040092389-A1 Double metal cyanide catalysts for the preparation of polyether polyols BAYER AKTIENGESELLSCHAFT (DE) 2004-05-13 US disclosed
EP-1386662-A1 Double metal cyanide catalysts for preparing polyether polyols Bayer Aktiengesellschaft (DE) 2004-02-04 EP disclosed